Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003627-20Phase 4Completed
Phase 4, randomised, open-label trial of salmeterol + fluticasone in asthma (4 arms), sponsored by University of Dundee. Primary endpoint: Overnight urinary cortisol-to-creatinine ratio. Started Dec 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003627-20.